HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

HYB-2055

immunomodulatory oligonucleotide, an agonist of toll-like receptor 9, for the potential treatment of cancer; in phase II clinical trials (8/2005)
Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Lasek, Witold: 1 article (08/2005)
2. Switaj, Tomasz: 1 article (08/2005)

Related Diseases

1. Neoplasms (Cancer)

Related Drugs and Biologics

1. Toll-Like Receptor 9

Related Therapies and Procedures

1. Injections